SYMBIO PHARM GMBH - Search on European Projects Archive

Ideas
Partners
Consultants
Calls
EU Projects
Blog NEW
- Europe towards City Innovation Hubs
  
  Written by Matteo Satta EU funding has always helped cities support their innovation processes, particularly on digital transformation and environment, but the approach is now moving toward a new ambitious […]
- Mistakes that Cities Should Be Avoiding in EU Projects
  
  By Matteo Satta Nowadays, we are seeing an increasing trend of people requesting to lower taxes and, as a result, public budgets. This leads many cities to try to find […]
- How a city can boost your Smart City project
  
  By Matteo Satta The commission has been heavily investing in pilot Smart City projects for a long time, but you may often have R&D or innovation projects pretending to have […]
- How to involve a city in your project? Here are a few tips.
  
  Article written by Matteo Satta (Smart) City projects are more and more funded by the European Commission, but consortia often struggle to get cities on board or really engage them. […]
- >> See all posts
Log In Sign Up

2 European Projects Found

Searched on 125080 European Projects

FINISHED

European Training in Neural Regulation of Intestinal Function (NeuroGut)

Start date: Feb 1, 2014, End date: Jan 31, 2018,

"Neurogastroenterology is a new and emerging medical/scientific subspecialty that currently has no formal training opportunities in medicine and related disciplines. It includes basic science aspects (neurophysiology, neurobiology, neuropsychology, psychophysiology) and clinical aspects (gastroenterology, neurology, internal medicine, surgery, psychology, psychosomatic medicine) of the neural cont ...

Read Project

12

Partners Participants Partners

FINISHED

Biopharmaceutical therapy for treatment of Primary Hyperoxaluria (ELIMOX)

Start date: Oct 1, 2013, End date: Sep 30, 2016,

"Interest in the use of naturally occurring human gut bacteria as pharmaceutical drugs has increased as knowledge about the human microbiota and its role in health and disease has advanced.The ELIMOX project proposes to develop a new drug from Oxalobacter formigenes, an anaerobic bacterium whose only carbon source is oxalate, for the treatment of primary hyperoxaluria (PH). PH is a rare and life-t ...

Read Project